Insiders · Profile

Renz Justin A

Chief Financial Officer at ARDELYX · EVP, CFO & Treasurer at Karyopharm Therapeutics. Filing since 2 Apr 2015. CIK 0001466562

Company
Date
Role
Action
Shares
Amount
Of holding
21 Aug 2025
Chief Financial Officer
Sold at will
7,037
$41.74K
1.7%
20 May 2025
Chief Financial Officer
Sold at will
7,218
$29.46K
1.7%
20 Feb 2025
Chief Financial Officer
Sold at will
5,171
$29.08K
1.8%
20 Nov 2024
Chief Financial Officer
Sold at will
5,260
$25.22K
1.8%
20 Aug 2024
Chief Financial Officer
Sold at will
5,289
$31.00K
1.8%
21 May 2024
Chief Financial Officer
Sold at will
5,167
$40.36K
1.7%
20 Feb 2024
Chief Financial Officer
Sold at will
5,341
$46.71K
1.7%
26 Dec 2023
Chief Financial Officer
Sold on a plan
225,000
$1.43M
55.2%
20 Nov 2023
Chief Financial Officer
Sold at will
2,873
$12.53K
0.9%
21 Aug 2023
Chief Financial Officer
Sold at will
2,884
$10.24K
0.9%
23 May 2023
Chief Financial Officer
Sold at will
2,873
$10.50K
0.8%
21 Feb 2023
Chief Financial Officer
Sold, plan not stated
3,439
$10.32K
1.0%
22 Nov 2022
Chief Financial Officer
Sold, plan not stated
1,504
$2.93K
0.6%
31 Aug 2022
Chief Financial Officer
Bought
3,000
$1.86K
1.2%
22 Aug 2022
Chief Financial Officer
Sold, plan not stated
1,498
$1.47K
0.6%
6 Jun 2022
Chief Financial Officer
Sold, plan not stated
73,312
$47.70K
21.9%
20 May 2022
Chief Financial Officer
Sold, plan not stated
1,528
$1.03K
0.5%
22 Feb 2022
Chief Financial Officer
Sold, plan not stated
1,800
$1.21K
0.5%
22 Nov 2021
Chief Financial Officer
Sold, plan not stated
643
$637.79
0.2%
20 Aug 2021
Chief Financial Officer
Sold, plan not stated
631
$832.92
1.6%
20 May 2021
Chief Financial Officer
Sold, plan not stated
612
$4.34K
1.5%
22 Feb 2021
Chief Financial Officer
Sold, plan not stated
608
$4.18K
1.5%
15 Sep 2020
Chief Financial Officer
Sold, plan not stated
3,714
$20.37K
28.6%
9 Nov 2016
EVP, CFO & Treasurer
Sold, plan not stated
4,342
$35.54K
18.5%
2 Apr 2015
EVP, CFO & Treasurer
Bought
5,000
$148.56K
opened
25 decisions on file.